Larimar Therapeutics Inc (LRMR)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS

THREE BALA PLAZA EAST. SUITE 506 BALA CYNWYD, PA 19004

Zafgen Inc. operates as a biopharmaceutical company. The company develops therapeutics for the treatment of obesity and co-morbidities. Zafgen serves customers worldwide.

Data as of 2021-05-08 11:29:32 -0400
Market Cap212.997 Million Shares Outstanding15.368 Million Avg 30-day Volume103.945 Thousand
P/E Ratio Dividend Yield EPS
Price/Sales Debt to Equity EBITDA
Price to Book Value0.0 Forward PE-4.26 Enterprise Value
Total Cash Current Debt Gross Profit
BETA1.71332 52-week High/Low25.87 / 0.78 Next Earnings Date Price to Cash FLow (P/CF) -9999999.0
Data provided by IEX Cloud
View SEC Filings from LRMR instead.
Q4 2020 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 5 3 66.67% 4 (0.24%) 2 (0.12%) 100.0%
Funds Holding: 44 39 12.82% 23 (1.38%) 21 (1.31%) 9.52%
13F shares: 14.252 Million 13.625 Million 4.6% 12.922 Million 12.402 Million 4.19%
% Ownership 92.8118 88.7266 4.6% 84.1468 80.7611 4.19%
New Positions: 11 6 83.33% 4 1 300.0%
Increased Positions 11 11 0.0% 6 6 0.0%
Closed Positions 6 5 20.0% 2 3 -33.33%
Reduced Positions 8 6 33.33% 4 4 0.0%
Total Calls 0 2 -100.0%
Total Puts 0
PUT/CALL Ratio 0.0
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding LRMR (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding LRMR BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

CELANO MICHAEL CHIEF FINANCIAL OFFICER

  • Officer
0 2021-01-19 4

BEN-MAIMON CAROLE PRESIDENT AND CEO

  • Officer
  • Director
0 2021-01-19 4

BARRETT PETER

  • Director
0 2020-09-29 1

THOMAS FRANK E

  • Director
0 2020-09-29 1

DANIEL THOMAS O

  • Director
0 2020-09-29 1

HAMILTON THOMAS EDWARD

  • Director
0 2020-09-29 3

LEFF JONATHAN S

  • Director
0 2020-09-29 2

TRUITT JOSEPH

  • Director
0 2020-09-29 2

FLYNN JAMES E

DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)

  • Director
  • 10% Owner
  • * DIRECTOR BY DEPUTIZATION* DIRECTOR BY DEPUTIZATION
0 2020-09-29 2

CHONDRIAL THERAPEUTICS HOLDINGS, LLC

  • 10% Owner
8 2020-06-26 2

FLYNN JAMES E

DEERFIELD MGMT III, L.P.

DEERFIELD MGMT IV, L.P.

DEERFIELD MGMT HIF, L.P.

DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)

DEERFIELD PRIVATE DESIGN FUND III, L.P.

DEERFIELD PRIVATE DESIGN FUND IV, L.P.

DEERFIELD HEALTHCARE INNOVATIONS FUND, L.P.

  • Director
  • 10% Owner
  • DIRECTOR BY DEPUTIZATIONDIRECTOR BY DEPUTIZATIONDIRECTOR BY DEPUTIZATIONDIRECTOR BY DEPUTIZATIONDIRECTOR BY DEPUTIZATIONDIRECTOR BY DEPUTIZATIONDIRECTOR BY DEPUTIZATIONDIRECTOR BY DEPUTIZATION
6,091,250 2020-05-28 2

LAMATTINA JOHN L

  • Director
0 2019-06-26 0

MCDONOUGH CAMERON GEOFFREY

  • Director
0 2019-06-26 0

PEREZ ROBERT J

  • Director
0 2019-06-26 0

EVERETT WENDY

  • Director
0 2019-06-26 0

SINGHAL PRIYA HEAD OF RESEARCH & DEVELOPMENT

  • Officer
0 2019-04-02 0

ALLEN PATRICIA L CHIEF FINANCIAL OFFICER

  • Officer
0 2019-01-22 0

KIM DENNIS D CHIEF MEDICAL OFFICER

  • Officer
0 2019-01-22 0

HATFIELD JEFFREY S. CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
0 2019-01-22 0

MCVEIGH BRIAN CHIEF BUSINESS OFFICER

  • Officer
0 2019-01-22 0

ATLAS VENTURE FUND VII L P

ATLAS VENTURE ASSOCIATES VII, L.P.

ATLAS VENTURE ASSOCIATES VII, INC.

  • 10% Owner
No longer subject to file 2018-06-29 0

HUGHES THOMAS E. SEE REMARKS

  • Officer
  • Director
125,247 2018-06-28 0

BOOTH BRUCE

  • Director
  • 10% Owner
0 2018-01-03 0

HELLER FRANCES K

  • Director
47,961 2017-10-13 0

FLYNN JAMES E

DEERFIELD MGMT L.P.

DEERFIELD PARTNERS, L.P.

DEERFIELD MANAGEMENT CO

DEERFIELD INTERNATIONAL MASTER FUND, L.P.

DEERFIELD SPECIAL SITUATIONS FUND, L.P.

  • 10% Owner
  • POSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUP
No longer subject to file 2016-07-20 0

LOUSTAU PATRICK PRESIDENT

  • Officer
0 2016-03-31 0

SECOR ALICIA CHIEF COMMERCIAL OFFICER

  • Officer
0 2016-03-31 0

STARR KEVIN P

  • Director
580,694 2015-09-24 0

GOLDBERG AVI Y.

  • Director
53,734 2015-09-18 0

THIRD ROCK VENTURES LP

THIRD ROCK VENTURES GP, L.P.

TRV GP, LLC

LEVIN MARK J

TEPPER ROBERT I

  • 10% Owner
No longer subject to file 2015-07-23 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
LARIMAR THERAPEUTICS INC LRMR 2021-05-11 22:15:03 UTC -1.4954 1.5454 450000
LARIMAR THERAPEUTICS INC LRMR 2021-05-11 21:45:03 UTC -1.4954 1.5454 450000
LARIMAR THERAPEUTICS INC LRMR 2021-05-11 21:15:03 UTC -1.4954 1.5454 450000
LARIMAR THERAPEUTICS INC LRMR 2021-05-11 20:45:03 UTC -1.4954 1.5454 450000
LARIMAR THERAPEUTICS INC LRMR 2021-05-11 20:15:03 UTC -1.4954 1.5454 450000
LARIMAR THERAPEUTICS INC LRMR 2021-05-11 19:45:03 UTC -1.4954 1.5454 450000
LARIMAR THERAPEUTICS INC LRMR 2021-05-11 19:15:02 UTC -1.4954 1.5454 450000
LARIMAR THERAPEUTICS INC LRMR 2021-05-11 18:45:02 UTC -1.4644 1.5144 450000
LARIMAR THERAPEUTICS INC LRMR 2021-05-11 18:15:03 UTC -1.4644 1.5144 450000
LARIMAR THERAPEUTICS INC LRMR 2021-05-11 17:45:03 UTC -1.4644 1.5144 450000
LARIMAR THERAPEUTICS INC LRMR 2021-05-11 17:15:04 UTC -1.4644 1.5144 450000
LARIMAR THERAPEUTICS INC LRMR 2021-05-11 16:45:04 UTC -1.34 1.39 450000
LARIMAR THERAPEUTICS INC LRMR 2021-05-11 16:15:04 UTC -1.34 1.39 450000
LARIMAR THERAPEUTICS INC LRMR 2021-05-11 15:45:03 UTC -1.34 1.39 450000
LARIMAR THERAPEUTICS INC LRMR 2021-05-11 15:15:03 UTC -1.34 1.39 450000
LARIMAR THERAPEUTICS INC LRMR 2021-05-11 14:45:03 UTC -0.9431 0.9931 450000
LARIMAR THERAPEUTICS INC LRMR 2021-05-11 14:15:03 UTC -0.9431 0.9931 450000
LARIMAR THERAPEUTICS INC LRMR 2021-05-11 13:45:04 UTC -0.9431 0.9931 450000
LARIMAR THERAPEUTICS INC LRMR 2021-05-11 13:15:04 UTC -0.9431 0.9931 450000
LARIMAR THERAPEUTICS INC LRMR 2021-05-11 12:45:03 UTC -0.9431 0.9931 500000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments